These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 7621249)

  • 1. Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.
    Banerjee D; Zhao SC; Tong Y; Steinherz J; Gritsman K; Bertino JR
    Cancer Gene Ther; 1994 Sep; 1(3):181-4. PubMed ID: 7621249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance.
    Banerjee D; Schweitzer BI; Volkenandt M; Li MX; Waltham M; Mineishi S; Zhao SC; Bertino JR
    Gene; 1994 Feb; 139(2):269-74. PubMed ID: 8112617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
    Affleck JG; Nowickyj SM; Walker VK
    Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double-mutant dihydrofolate reductase gene transfection into bone marrow cells protects mice from chemotherapy].
    Gao HD; Lu P; Lu Y; Pang K; Xu HM; Wang SB; Chen JQ; Zhao SC
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):583-5. PubMed ID: 17236551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel RNA silencing vector to improve antigen expression and stability in Chinese hamster ovary cells.
    Hong WW; Wu SC
    Vaccine; 2007 May; 25(20):4103-11. PubMed ID: 17428585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
    James RI; May C; Vagt MD; Studebaker R; McIvor RS
    Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.
    Zhao SC; Li MX; Banerjee D; Schweitzer BI; Mineishi S; Gilboa E; Bertino JR
    Cancer Gene Ther; 1994 Mar; 1(1):27-33. PubMed ID: 7621235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene.
    Cowan KH; Goldsmith ME; Ricciardone MD; Levine R; Rubalcaba E; Jolivet J
    Mol Pharmacol; 1986 Jul; 30(1):69-76. PubMed ID: 3724746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of human prothrombin in permanent cell lines using a dominant selection/amplification fusion marker.
    Herlitschka SE; Falkner FG; Schlokat U; Dorner F
    Protein Expr Purif; 1996 Nov; 8(3):358-64. PubMed ID: 8936598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene.
    Capiaux GM; Budak-Alpdogan T; Alpdogan O; Bornmann W; Takebe N; Banerjee D; Maley F; Bertino JR
    Cancer Gene Ther; 2004 Dec; 11(12):767-73. PubMed ID: 15359285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
    Volpato JP; Fossati E; Pelletier JN
    J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of human-mouse chimeric antibody ch-BD1 and its affinity to human bladder cancer in vitro and in vivo].
    Bai Y; Yu LZ; Lü YQ; Ai JK; Zhou LJ; Zhang CL; Wang Y
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):333-7. PubMed ID: 12812655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short hairpin RNA targeted to dihydrofolate reductase enhances the immunoglobulin G expression in gene-amplified stable Chinese hamster ovary cells.
    Wu SC; Hong WW; Liu JH
    Vaccine; 2008 Sep; 26(38):4969-74. PubMed ID: 18602963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
    Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
    Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
    McIvor RS
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S50-4. PubMed ID: 8971409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells.
    Ringold G; Dieckmann B; Lee F
    J Mol Appl Genet; 1981; 1(3):165-75. PubMed ID: 6180118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.